Меню
Идёт набор NCT05690737

Tai Chi for the Prophylaxis of Episodic Migraine: the Efficacy Examination and Mechanism Exploration

Без фазы С лечением Migraine Disorders

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Tai Chi training, Standard prophylactic medication.
Кому может быть актуально
Состояния в реестре: Migraine Disorders. Базовые параметры: 18 лет — 65 лет · Женщины.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Гонконг
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

A Randomized Controlled Trail to Examine the Efficacy of Tai Chi for the Prophylaxis of Episodic Migraine Compared With Standard Prophylactic Medication in Chinese Women and a Pre-post Neuroimaging and Laboratory-based Study to Explore the Mechanism of Tai Chi's Intervention Effect

Обзор

The proposed study aims to examine the clinical efficacy of 24-week Tai Chi training in the prophylaxis of episodic migraine comparing with standard prophylactic medication in Hong Kong Chinese women, and to explore the mechanism of Tai Chi's intervention effect by examining the associations of changes in migraine features with neurovascular and neuroinflammation variations.

Подробное описание

A two-arm individual level randomized controlled trial is designed. A total of 220 local women diagnosed with episodic migraine between 18-65 years will be randomly assigned to one of two groups: 1) a Tai Chi training group receiving the 33-short form Yang-style Tai Chi training; or 2) a standard prophylactic medication group receiving the regular medication prescribed by the neurologist. The intervention period will be 24 weeks with another 24 weeks follow-up. The frequency of migraine attack, migraine days, intensity and duration of headache will be recorded by a migraine diary at the baseline, 24th weeks, and 48th weeks. Other outcomes including migraine related disability, stress, sleep quality, fatigue, and QOL will be measured at these three time points. The clinical efficacy will be determined by comparing the differences of outcomes from baseline to the end of the trial between two groups. The MRI and TCD will be used to measure the degree of white matter abnormality and cerebrovascular function, respectively; and the inflammatory markers will also be tested at three time points for Tai Chi participants. The mechanism of intervention effect will be explored by analyzing the changes and associations of migraine features with the process of these neurovascular functions and inflammatory markers during and after the Tai Chi training.

Вмешательства

  • Поведенческое Tai Chi training
    The 24-week Tai Chi training will be prescribed with three 1-hour instructor-led sessions and two 1-hour self-practice sessions per week. A modified 33-short form Yang-style Tai Chi Chuan will be adopted. The Tai Chi sessions will be operated by qualified/certified instructors. Each 1-hour training session will consist of 10 minutes brief warm-up stretching session followed by 45 minutes standard Tai Chi routine activities, and 5 minutes of cool-down stretching. The Tai Chi instructors will have
  • Препарат Standard prophylactic medication
    Participants assigned to the control group will follow the collaborated neurologist's recommendation, to take the prophylactic medication. The Multidisciplinary Panel on Neuropathic Pain (MPNP) of Hong Kong has published the treatment algorithm for migraine, which is in line with the guideline of the Scottish Intercollegiate Guidelines Network (SIGN) on the pharmacological management of migraine (SIGN 155). Beta-blockers, specifically metoprolol and propranolol, are one of the first-line treatme

Первичные конечные точки

  • The difference in frequency of migraine attacks [Срок оценки: Between 4 weeks before randomization and weeks 21-24 / 45-48 after randomization]
  • The difference in frequency of migraine days [Срок оценки: Between 4 weeks before randomization and weeks 21-24 / 45-48 after randomization]
  • The difference of white matter abnormalities (WMAs) [Срок оценки: From the baseline to 24 weeks and 48 weeks]
  • The difference of pulsatility index (PI) [Срок оценки: From the baseline to 24 weeks and 48 weeks]
  • The difference of mean blood flow velocity (MBFV) [Срок оценки: From the baseline to 24 weeks and 48 weeks]
  • The difference of impaired cerebrovascular responsiveness (CVR). [Срок оценки: From the baseline to 24 weeks and 48 weeks]
Вторичные конечные точки (12)
  • The proportion of responders [Срок оценки: Between 4 weeks before randomization and weeks 21-24 / 45-48 after randomization]
  • The intensity of the headache [Срок оценки: Between 4 weeks before randomization and weeks 21-24 / 45-48 after randomization]
  • The duration of headache [Срок оценки: Between 4 weeks before randomization and weeks 21-24 / 45-48 after randomization]
  • Migraine related disability [Срок оценки: From the baseline to 24 weeks and 48 weeks]
  • Stress level [Срок оценки: From the baseline to 24 weeks and 48 weeks]
  • Sleep quality [Срок оценки: From the baseline to 24 weeks and 48 weeks]
  • Fatigue level [Срок оценки: From the baseline to 24 weeks and 48 weeks]
  • Health related Quality-of-Life [Срок оценки: From the baseline to 24 weeks and 48 weeks]
  • Weight [Срок оценки: From the baseline to 24 weeks and 48 weeks]
  • Height [Срок оценки: From the baseline to 24 weeks and 48 weeks]
  • Waist circumference [Срок оценки: From the baseline to 24 weeks and 48 weeks]
  • Hip circumference [Срок оценки: From the baseline to 24 weeks and 48 weeks]

Критерии участия

Критерии включения

  • Chinese woman, aged 18-65 years.
  • Have a clinical diagnosis of episodic migraine (migraine with less than 15 attacks per month) with or without aura according to the International Classification of Headache Disorders, 3rd edition (ICHD-3).
  • First migraine attack before the age of 45 years.
  • Between two and six migraine attacks in one month.
  • At least one of the following migraine characteristics is met: nausea, vomiting, photophobia, or phonophobia.
  • Duration of migraine attacks is 2-72 h without acute medication or at least 1 h with acute medication.
  • Able to undertake designated level of Tai Chi exercise.
  • Live in Hong Kong.

Критерии исключения

  • Severe migraine attacks with disabilities that cannot perform moderate intensity physical activity.
  • Secondary headache and other neurological disease.
  • More than 5 days of non-migrainous headache per month.
  • Experience with Tai Chi or other body-mind exercises (yoga, biofeedback, medication, etc.) after diagnosis of migraine.
  • Undergoing other alternative therapeutic treatments during recruitment period, or received other alternative therapeutic treatments in the past 12 weeks.
  • Pregnancy, lactation period, or currently using contraceptives.
  • Use of pharmacological prophylactic treatment for migraine in the past 12 weeks.
  • Drug abuse, take antipsychotic or antidepressant drugs, or take analgesics for other chronic pain more than 3 days a month in the past 12 weeks.
  • Epilepsy, or have a psychiatric disease.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Простое слепое
Основная цель
Лечение

Центры проведения

Гонконг · 2 центра
  • The Hong Kong Polytechnic University — Гонконг
  • The Hong Kong Polytechnic University — Hung Hom

Публикации

  • Xie YJ, Liao X, Hui SS, Tian L, Yeung WF, Lau AY, Tyrovolas S, Gao Y, Chen X. Tai Chi for the prophylaxis of episodic migraine: protocol of a non-inferiority randomized controlled trial with mechanism exploration. BMC Complement Med Ther. 2023 Sep 18;23(1):328. doi: 10.1186/s12906-023-04154-x. PMID 37723467

Идентификаторы

NCT: NCT05690737 · A0041948

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗